Trial Details

COMPLETED
Basic Information
Clinical ID c3209
Identifier NCT02389790
Trial Title Extension Study of MT-1303 in Subjects With Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: MT-1303
Participant Information
Sponsor Tanabe Pharma Corporation
City City Name
Country/Region Czechia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2015-08
Primary Completion Date 2017-08
Completion Date 2017-08